NATCO Pharma Limited
NSE:NATCOPHARM.NS
1,389.2 (INR) • At close October 17, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | NATCO Pharma Limited |
Symbool | NATCOPHARM.NS |
Munteenheid | INR |
Prijs | 1,389.2 |
Beurswaarde | 248,819,612,000 |
Dividendpercentage | 0.96% |
52-weken bereik | 724.2 - 1,639 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Rajeev Nannapaneni |
Website | https://www.natcopharma.co.in |
An error occurred while fetching data.
Over NATCO Pharma Limited
NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc.; and APIs in various categories, such as oncology, central nervous system, pain management, and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)